Warther Private Wealth LLC decreased its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 77.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,567 shares of the pharmacy operator's stock after selling 18,780 shares during the period. Warther Private Wealth LLC's holdings in CVS Health were worth $250,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Assetmark Inc. raised its position in CVS Health by 9.7% during the 3rd quarter. Assetmark Inc. now owns 410,001 shares of the pharmacy operator's stock valued at $25,781,000 after purchasing an additional 36,132 shares during the last quarter. TD Private Client Wealth LLC grew its holdings in shares of CVS Health by 28.7% during the 3rd quarter. TD Private Client Wealth LLC now owns 46,938 shares of the pharmacy operator's stock worth $2,951,000 after acquiring an additional 10,465 shares during the period. Cullinan Associates Inc. grew its holdings in shares of CVS Health by 43.8% during the 3rd quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator's stock worth $7,125,000 after acquiring an additional 37,395 shares during the period. Principal Financial Group Inc. grew its holdings in shares of CVS Health by 4.8% during the 3rd quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator's stock worth $90,200,000 after acquiring an additional 66,244 shares during the period. Finally, Sompo Asset Management Co. Ltd. grew its holdings in shares of CVS Health by 8.4% during the 3rd quarter. Sompo Asset Management Co. Ltd. now owns 134,523 shares of the pharmacy operator's stock worth $8,459,000 after acquiring an additional 10,453 shares during the period. Institutional investors own 80.66% of the company's stock.
Analysts Set New Price Targets
CVS has been the topic of a number of research analyst reports. Wells Fargo & Company upped their target price on CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a report on Thursday. Leerink Partners upgraded CVS Health from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $55.00 to $75.00 in a report on Thursday. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price on the stock in a report on Tuesday, December 3rd. UBS Group cut their price target on CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research note on Tuesday. Finally, Piper Sandler cut their price target on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average price target of $70.28.
Check Out Our Latest Research Report on CVS
CVS Health Stock Performance
Shares of NYSE CVS traded down $0.67 during midday trading on Friday, hitting $65.71. 10,208,186 shares of the stock traded hands, compared to its average volume of 12,149,901. The firm has a 50-day moving average of $51.11 and a two-hundred day moving average of $56.08. The firm has a market capitalization of $82.68 billion, a P/E ratio of 16.68, a PEG ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75.
CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. On average, equities analysts forecast that CVS Health Co. will post 5.14 EPS for the current fiscal year.
CVS Health Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.05%. CVS Health's payout ratio is 67.51%.
CVS Health Company Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
